IL13 and pulmonary fibrosis: Notably, it remains to be seen whether the pro-fibrotic activity of IL-13 is of clinically high enough relevance to render a vaccination treatment effective in several conditions involving increased fibrosis (e.g. hepatic fibrosis, pulmonary fibrosis due to various etiologies).